335 related articles for article (PubMed ID: 10594341)
1. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
Persson K; Andersson RG
Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
[TBL] [Abstract][Full Text] [Related]
2. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
Persson K; Andersson RG
J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro.
Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG
Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1.
Raffai G; Khang G; Vanhoutte PM
J Cardiovasc Pharmacol; 2014 May; 63(5):453-60. PubMed ID: 24390175
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
6. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
7. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
Miyamoto A; Murata S; Nishio A
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
[TBL] [Abstract][Full Text] [Related]
8. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
Félétou M; Germain M; Teisseire B
Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
11. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
12. Femtomolar bradykinin-induced relaxation of isolated bovine coronary arteries, mediated by endothelium-derived nitric oxide.
Nakamura Y; Kawagoe K; Obi T; Miyamoto A; Ishiguro S; Nishio A
J Vet Pharmacol Ther; 1998 Aug; 21(4):304-8. PubMed ID: 9731953
[TBL] [Abstract][Full Text] [Related]
13. Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery.
Krassói I; Pataricza J; Torday LL; Kun A; Papp JG
Ann Thorac Surg; 2000 Sep; 70(3):878-82. PubMed ID: 11016327
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
[TBL] [Abstract][Full Text] [Related]
16. Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril.
Gragasin FS; Bourque SL; Davidge ST
Anesth Analg; 2013 Apr; 116(4):775-83. PubMed ID: 23429803
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
18. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Zanzinger J; Zheng X; Bassenge E
Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360
[TBL] [Abstract][Full Text] [Related]
20. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
